Brief: Athenex Inc Provides Update From FDA Type A Meeting Regarding Oral Paclitaxel + Encequidar In Metastatic Breast Cancer
11/10/2021 13:13
Oct 11 (Reuters) - Athenex Inc ATNX.O :
* ATHENEX PROVIDES UPDATE FROM FDA TYPE A MEETING REGARDING
ORAL
PACLITAXEL + ENCEQUIDAR IN METASTATIC BREAST CANCER
* ATHENEX INC - TO REDEPLOY RESOURCES TO FOCUS ON OTHER
ONGOING
STUDIES OF ORAL PACLITAXEL AND PROMISING CAR-NKT AND TCR-T CELL
THERAPIES
Source text for Eikon: ID:nGNXJkck7
Further company coverage: ATNX.O